You are here

Literature Review

Postmenopausal Osteoporosis: Current and Future Treatment Options

Carrie McAdam-Marx, RPh, MS, Joanne LaFleur, PharmD, MSPH, Carmen Kirkness, MSc, PT, and Carl Asche, PhD
PDF version: 
The authors report on the efficacy and cost-effectiveness of antiresorptive medications (bisphosphonates, selective estrogen receptor modulators, and calcitonin); anabolic agents (parathyroid hormone); and strontium ranelate, all of which show promise in preventing fractures in women with osteoporosis after menopause.